Name | Bafilomycin B1 |
---|---|
Synonyms |
(5R)-2,4-Dideoxy-1-C-{(2S,3R,4S)-3-hydroxy-4-[(3S,4Z,9S,10S,11R)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]-2-pentanyl}-3-O-{(2E)-4-[(2-hydroxy-5-ox ;o-1-cyclopenten-1-yl)amino]-4-oxo-2-butenoyl}-5-isopropyl-4-methyl-α-D-threo-pentopyranose
BAFILOMYCIN B1 MONOHYDRATE FROM STREPTO-MYCES SPECIES bafilomycin b1from streptomyces sp. α-D-threo-Pentopyranose, 2,4-dideoxy-1-C-[(1S,2R,3S)-2-hydroxy-3-[(3S,4Z,9S,10S,11R)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]-1-methylbutyl]-3 -O-[(2E)-4-[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]-1,4-dioxo-2-buten-1-yl]-4-methyl-5-C-(1-methylethyl)-, (5R)- ino)carbonyl)-2-methoxy-24-methyl BafilomycinB1fromStreptomycesgriseus MFCD00214150 |
Description | Bafilomycin B1 is a macrolide antibiotic isolated from Streptomyces sp, inhibits Gram-positive bacteria and fungi, and acts as an inhibitor of K+-dependent ATPase of E. coli[1]. |
---|---|
Related Catalog | |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 939.4±65.0 °C at 760 mmHg |
Molecular Formula | C44H65NO13 |
Molecular Weight | 815.986 |
Flash Point | 521.9±34.3 °C |
Exact Mass | 815.445618 |
PSA | 207.38000 |
LogP | 3.06 |
Vapour Pressure | 0.0±0.6 mmHg at 25°C |
Index of Refraction | 1.563 |
Storage condition | −20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
![]() GHS06 |
---|---|
Signal Word | Danger |
Hazard Statements | H300 + H310 + H330 |
Precautionary Statements | P260-P264-P280-P284-P301 + P310-P302 + P350 |
Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
Hazard Codes | T+: Very toxic; |
Risk Phrases | R26/27/28 |
Safety Phrases | 36/37/39-45 |
RIDADR | UN 3462 6.1/PG 1 |
WGK Germany | 3 |
RTECS | NG8841000 |
Precursor 0 | |
---|---|
DownStream 1 | |